Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding
Clinical trial NCT00152399 · COMPLETED
Trial details
- NCT number
- NCT00152399
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-09-01
- Primary completion
- 2005-10-01
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.